Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy

被引:3
|
作者
Sun, Daokun [1 ]
Schaff, Hartzell, V [1 ]
Nishimura, Rick A. [2 ]
Geske, Jeffrey B. [2 ]
Dearani, Joseph A. [1 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
关键词
hypertrophic cardiomyopathy; diastolic heart failure; repeat operation; transapical myectomy; CAVITY OBLITERATION; EXERCISE CAPACITY; MECHANISMS; VOLUME;
D O I
10.1016/j.xjtc.2021.10.050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Some patients with obstructive hypertrophic cardiomyopathy may remain limited after surgical relief of the subaortic obstruction. In this report, we describe experience in surgical management of patients with advanced diastolic heart failure symptoms after adequate transaortic septal myectomy for obstructive hypertrophic cardiomyopathy. Methods: We identified adult patients who presented with heart failure symptoms after previous transaortic septal myectomy for obstructive hypertrophic cardiomyopathy and underwent repeat sternotomy for transapical myectomy to enlarge a small left ventricular cavity. Functional recovery after hospital dismissal was assessed through a questionnaire-based survey. Results: Six patients with previous septal myectomy presented with New York Heart Association functional class III symptoms. Preoperative transthoracic Doppler echocardiography confirmed adequate relief of subaortic outflow tract obstruction with only trivial or mild mitral valve regurgitation; left atrial volume index was increased at 46 mL/m(2) (range, 44-47 mL/m(2)). Following transapical myectomy, the left ventricular diameter was enlarged from 23 mm (range, 21-27 mm) to 29 mm (range, 27-31 mm) at end-systole and from 40 mm (range, 38-42 mm) to 43 mm (range, 42-50 mm) at end-diastole. All the patients were alive after a median follow-up of 0.6 years (range, 0.4-3.5 years), and 5 patients responded to a postoperative survey and indicated improvement in their heart condition compared with functional status before the repeat myectomy. Conclusions: Patients with diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy may present with systolic cavity obliteration due to excessive myocardial hypertrophy. Repeat transapical myectomy can enlarge the left ventricular chamber and augment the diastolic volume, which results in improved physical capacity and patient-perceived functional status. (JTCVS Techniques 2022;11:21-6)
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [21] Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
    Cui, Hao
    Schaff, Hartzell, V
    Wang, Shuiyun
    Lahr, Brian D.
    Rowin, Ethan J.
    Rastegar, Hassan
    Hu, Shengshou
    Eleid, Mackram F.
    Dearani, Joseph A.
    Kimmelstiel, Carey
    Maron, Barry J.
    Nishimura, Rick A.
    Ommen, Steve R.
    Maron, Martin S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) : 1647 - 1655
  • [22] Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy
    Wells, Sophie
    Rowin, Ethan J.
    Boll, Griffin
    Rastegar, Hassan
    Wang, Wendy
    Maron, Martin S.
    Maron, Barry J.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (06) : E234 - E239
  • [23] Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy
    Ha, Kyung Eun
    Choi, Kang-Un
    Lee, Hee-Jung
    Gwak, Seo-Yeon
    Kim, Kyu
    Cho, Iksung
    Hong, Geu-Ru
    Ha, Jong-Won
    Shim, Chi Young
    ESC HEART FAILURE, 2023, 10 (05): : 2939 - 2947
  • [24] Virtual surgical myectomy as a planning tool for obstructive hypertrophic cardiomyopathy
    Prahlad G Menon
    Parachuri V Rao
    Srilakshmi M Adhyapak
    Ou Yuanchang
    Richard Weeks
    Journal of Cardiovascular Magnetic Resonance, 18 (Suppl 1)
  • [25] Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy
    Geske, Jeffrey B.
    Konecny, Tomas
    Ommen, Steve R.
    Nishimura, Rick A.
    Sorajja, Paul
    Schaff, Hartzell V.
    Ackerman, Michael J.
    Gersh, Bernard J.
    EUROPEAN HEART JOURNAL, 2014, 35 (30) : 2032 - 2039
  • [26] Effect of Septal Myectomy on Obstructive Sleep Apnoea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy
    Wang, Shengwei
    Cui, Hao
    Meng, Liukun
    Wu, Rong
    Tang, Bing
    Zhu, Changsheng
    Yu, Qinjun
    Huang, Xiaohong
    Wang, Shuiyun
    HEART LUNG AND CIRCULATION, 2020, 29 (09) : 1366 - 1374
  • [27] Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
    McLeod, Christopher J.
    Ommen, Steve R.
    Ackerman, Michael J.
    Weivoda, Peggy L.
    Shen, Win K.
    Dearani, Joseph A.
    Schaff, Hartzell V.
    Tajik, A. Jamil
    Gersh, Bernard J.
    EUROPEAN HEART JOURNAL, 2007, 28 (21) : 2583 - 2588
  • [28] Ablation of ventricular tachycardia after septal myectomy for hypertrophic cardiomyopathy
    Demirtas, Abdullah Orhan
    Singh, Sheldon M.
    JOURNAL OF ARRHYTHMIA, 2024, 40 (03) : 636 - 638
  • [29] Improvement in gastrointestinal bleeding after septal myectomy for hypertrophic cardiomyopathy
    Sun, Daokun
    Schaff, Hartzell V.
    Carvalho, Juliano Lentz
    Nishimura, Rick A.
    Dearani, Joseph A.
    Ommen, Steve R.
    Blackshear, Joseph L.
    Geske, Jeffrey B.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (01) : 157 - 163
  • [30] Virtual septal myectomy for preoperative planning in hypertrophic cardiomyopathy
    Takayama, Hiroo
    Yu, Sarah N.
    Sorabella, Robert
    Leb, Jay
    Pulerwitz, Todd C.
    Cooper, Cathleen
    Argenio, Melissa
    Shimada, Yuichi J.
    Weiner, Shepard
    Ginns, Jonathan N.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (02) : 455 - 463